0001477932-24-005024.txt : 20240816 0001477932-24-005024.hdr.sgml : 20240816 20240816160536 ACCESSION NUMBER: 0001477932-24-005024 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240815 FILED AS OF DATE: 20240816 DATE AS OF CHANGE: 20240816 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Reynolds Cameron John CENTRAL INDEX KEY: 0001340610 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36833 FILM NUMBER: 241216707 MAIL ADDRESS: STREET 1: 1489 WEST WARM SPRINGS ROAD STREET 2: SUITE 110 CITY: HENDERSON STATE: NV ZIP: 89014 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: VOLITIONRX LTD CENTRAL INDEX KEY: 0000093314 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 911949078 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1489 WEST WARM SPRINGS ROAD STREET 2: SUITE 110 CITY: HENDERSON STATE: NV ZIP: 89014 BUSINESS PHONE: 1 (646) 650-1351 MAIL ADDRESS: STREET 1: 1489 WEST WARM SPRINGS ROAD STREET 2: SUITE 110 CITY: HENDERSON STATE: NV ZIP: 89014 FORMER COMPANY: FORMER CONFORMED NAME: STANDARD CAPITAL CORP DATE OF NAME CHANGE: 19990812 4 1 form4.xml FORM 4 X0508 4 2024-08-15-05:00 false 0000093314 VOLITIONRX LTD VNRX 0001340610 Reynolds Cameron John 1489 WEST WARM SPRINGS ROAD SUITE 110 HENDERSON NV 89014 true true false false President and CEO false Common Stock 2024-08-15-05:00 4 A false 29500 0.0 A 1874350 D Common Stock 1007718 I By Concord International, Inc. Common Stock 34076 I By Spouse On Sept 28, 2023, the reporting person was awarded 118,000 restricted stock units ("RSUs") under the Issuer's 2015 Stock Incentive Plan, subject to vesting upon the achievement of certain corporate performance goals on or prior to Dec 31, 2023 and June 30, 2024 and also subject to time-based vesting. Certain of the performance goals were met, resulting in the rights with respect to 29,500 RSUs vesting. The RSUs are further subject to a 3-year time-based vesting schedule, vesting in three installments of 9,833 units, 9,833 units, and 9,834 units on each of Sept 28, 2024, 2025 and 2026, respectively. Upon vesting and settlement, the reporting person will receive a number of shares of common stock equal to the number of RSUs that have vested. As reported in Jan 2024, the rights with respect to 50,150 RSUs subject to the award previously vested and remain subject to time-based vesting. The rights with respect to the remaining 38,350 RSUs did not vest and were cancelled on August 15, 2024. The shares of common stock are held directly by Concord International, Inc. Mr. Reynolds is the majority shareholder of Concord International, Inc. and shares voting and dispositive control over the shares of common stock held by Concord International, Inc. /s/ Cameron John Reynolds 2024-08-16-05:00